ALLMedicine™ Plaque Psoriasis Center

Sep 15th, 2021 - Guselkumab is an interleukin (IL)-23 pathway blocker with proven efficacy in patients with moderate-to-severe plaque psoriasis. Early intervention with guselkumab may result in changes to the clinical disease course versus later intervention. Here...

Sep 9th, 2021 - Psoriasis is a chronic inflammatory hyper proliferative skin disease. Angiogenesis play an important role in Psoriasis pathogenesis, occurring even before plaque formation. Angiopoietins play an important role in angiogenesis and hence are describ...

Sep 8th, 2021 - Psoriasis is a chronic immune-mediated inflammatory skin disease which can also involve joints. It is often associated with burdensome comorbidities which negatively impact prognosis and quality of life (QoL). Biologic agents have been shown to be...

Sep 3rd, 2021 - This analysis assessed the psychometric properties of the Psoriasis Symptoms and Impacts Measure (P-SIM), a novel patient-reported outcome (PRO) tool designed to capture patient experiences of the signs, symptoms and impacts of psoriasis. Blinded ...

Sep 1st, 2021 - Psoriatic arthritis (PsA) is an inflammatory form of arthritis that appears approximately 7-10 years after psoriasis and remains undiagnosed in most of patients. Currently, only a few quantitative and succinct PsA-risk prediction models are availa...

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

Aug 25th, 2021 - The purpose of the study is to evaluate the efficacy and safety of bimekizumab compared with placebo.

Jun 14th, 2021 - Psoriasis is a common skin disorder affecting up to an estimated 3% of the world's population. The most prevalent form of psoriasis, called psoriasis vulgaris or plaque psoriasis, is characterized by the presence of sharply demarcated erythematous...

Oct 30th, 2020 - This study is to evaluate available local data in Iraqi patients with moderate to severe psoriasis on Enbrel treatment with regards to efficacy, treatment regimen adherence and patient characterization (i.e. age, gender, smoking status) using data...

Mar 15th, 2017 - The recommended starting dose of etanercept for adult plaque psoriasis patients is a 50 mg dose given twice a week (BIW) for 3 months followed by a reduction to a maintenance dose of 50 mg once weekly (QW). While most patients with moderate to sev...

Jul 9th, 2015 - This was a multi-center, prospective, post-marketing observational study of participants with severe chronic plaque psoriasis who began adalimumab therapy in the United Kingdom. Although 153 participants enrolled in the study, data was only analyz...

Jul 9th, 2021 - Psoriasis is a chronic, immune-mediated inflammatory skin disease. Globally, approximately 125 million people have psoriasis, which manifests in several ways (ie, plaque, flexural, guttate, pustular, or erythrodermic psoriasis). Plaque psoriasis i...

Jul 9th, 2021 - Plaque psoriasis is the most common form of psoriasis, a chronic inflammatory skin disorder that affects approximately 125 million individuals worldwide. It exerts a considerable burden on affected patients, including decreased quality of life and...

Jun 24th, 2021 - Patients with psoriasis treated with biological disease-modifying antirheumatic drugs had a significantly lower incidence of psoriatic arthritis (PsA) compared with those treated with phototherapy, in a study of 464 adults. Epidemiologic data show...

Jun 14th, 2021 - Approximately 125 million people around the world have psoriasis, a chronic, relapsing inflammatory skin disorder. Several clinical variants of psoriasis are recognized, but plaque psoriasis is the most common. Psoriasis is associated with a signi...

Jun 14th, 2021 - Psoriasis affects at least 100 million people worldwide, with plaque psoriasis (also referred to as psoriasis vulgaris) being the most common form. Although many different medication options are available for psoriasis, the type of treatment presc...